Literature DB >> 3193820

Diagnosing Lyme disease: the contribution of serologic testing.

J Duffy1, L E Mertz, G H Wobig, J A Katzmann.   

Abstract

Lyme disease is a multisystem disorder caused by a tick-transmitted spirochete, Borrelia burgdorferi. The diagnosis is based on clinical findings in most patients, particularly those with erythema migrans or exposure to geographic locations endemic for the disease. Detection of a specific antibody to B. burgdorferi is a useful confirmatory test in many patients. In atypical cases, however, a positive test result can be pivotal for determining the diagnosis and can lead to institution of definitive treatment. Serologic testing should not be used indiscriminately to diagnose Lyme disease or as the sole basis for administration of antibiotic therapy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3193820     DOI: 10.1016/s0025-6196(12)65506-2

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  5 in total

1.  Laboratory confirmation of Lyme disease.

Authors:  T G Schwan; W J Simpson; P A Rosa
Journal:  Can J Infect Dis       Date:  1991

2.  A 49-year-old man with aseptic meningitis and multiple cranial neuropathies.

Authors:  J C Mazziotta; H Itabashi; C Orfuss; A Charles; R Collins
Journal:  West J Med       Date:  1991-03

Review 3.  Childhood Lyme borreliosis in Europe.

Authors:  H I Huppertz
Journal:  Eur J Pediatr       Date:  1990-09       Impact factor: 3.183

4.  False positive ELISA serologic test for Lyme borreliosis in patients with connective tissue diseases.

Authors:  B Keymeulen; G Somers; A Naessens; L A Verbruggen
Journal:  Clin Rheumatol       Date:  1993-12       Impact factor: 2.980

5.  Lyme disease assay which detects killed Borrelia burgdorferi.

Authors:  S M Callister; R F Schell; S D Lovrich
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.